Gil Milner
Director Financiero/CFO en ROBOGROUP T.E.K. LTD. .
Cargos activos de Gil Milner
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| GLOBE EXPLORATION (Y.C.D.) LIMITED PARTNERSHIP | Director/Miembro de la Junta | 18/06/2019 | - |
| Independent Dir/Board Member | 18/06/2019 | - | |
| ROBOGROUP T.E.K. LTD. | Director Financiero/CFO | - | - |
| Consus Ltd. | Director/Miembro de la Junta | - | - |
Historial de carrera de Gil Milner
Antiguos cargos conocidos de Gil Milner.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| ANCHIANO THERAPEUTICS LTD. | Director/Miembro de la Junta | 25/11/2012 | 01/07/2015 |
BioCancell Therapeutics, Inc.
 BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | Director/Miembro de la Junta | 01/11/2012 | - |
Campus Bio Management Ltd.
 Campus Bio Management Ltd. Pharmaceuticals: MajorHealth Technology Campus Bio Management Ltd. engages in the development of biopharmaceuticals and medical devices licensed from academic institutes for cancer and inflammatory diseases. The company was founded in May 2008 and is headquartered in Tel Aviv, Israel. | Director/Miembro de la Junta | - | - |
| CLAL BIOTECHNOLOGY INDUSTRIES LTD. | Comptroller/Controller/Auditor | 31/05/2007 | - |
| Director Financiero/CFO | 22/03/2010 | - | |
Clal Biotechnology Industries Ltd. (Venture Capital)
 Clal Biotechnology Industries Ltd. (Venture Capital) Investment ManagersFinance Clal Biotechnology Industries Ltd. (Clal Biotechnology Industries) is a venture capital division of Clal Biotechnology Industries Ltd. founded in 1993. The firm is headquartered in Tel Aviv, Israel. | Director Financiero/CFO | - | - |
Formación de Gil Milner.
| Bar-Ilan University | Undergraduate Degree |
Estadísticas
Internacional
| Israel | 8 |
| Estados Unidos | 3 |
Operativa
| Director/Board Member | 5 |
| Director of Finance/CFO | 3 |
| Comptroller/Controller/Auditor | 1 |
Sectorial
| Health Technology | 4 |
| Finance | 3 |
| Consumer Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| CLAL BIOTECHNOLOGY INDUSTRIES LTD. | Finance |
| GLOBE EXPLORATION (Y.C.D.) LIMITED PARTNERSHIP | Energy Minerals |
| ROBOGROUP T.E.K. LTD. | Technology Services |
| Empresas privadas | 5 |
|---|---|
Clal Biotechnology Industries Ltd. (Venture Capital)
Clal Biotechnology Industries Ltd. (Venture Capital) Investment ManagersFinance Clal Biotechnology Industries Ltd. (Clal Biotechnology Industries) is a venture capital division of Clal Biotechnology Industries Ltd. founded in 1993. The firm is headquartered in Tel Aviv, Israel. | Finance |
Anchiano Therapeutics Ltd.
 Anchiano Therapeutics Ltd. BiotechnologyHealth Technology Anchiano Therapeutics Ltd. is a clinical-stage biopharmaceutical company, which engages in tin the discovery, development and commercialization of drugs for cancer-related diseases. Its products include two drugs for cancer BC-819 and BC-821. The company was founded by Avraham Hochberg in 2004 and is headquartered in Jerusalem, Israel. | Health Technology |
Campus Bio Management Ltd.
Campus Bio Management Ltd. Pharmaceuticals: MajorHealth Technology Campus Bio Management Ltd. engages in the development of biopharmaceuticals and medical devices licensed from academic institutes for cancer and inflammatory diseases. The company was founded in May 2008 and is headquartered in Tel Aviv, Israel. | Health Technology |
BioCancell Therapeutics, Inc.
BioCancell Therapeutics, Inc. BiotechnologyHealth Technology BioCancell Therapeutics, Inc. is a development-stage biopharmaceutical company, which is focused on the discovery, development and commercialization of novel therapies for treating cancer-related diseases. The company's technology offers a safe and long-term treatment of cancer, with no adverse effects. The drug candidates developed by the company are targeted and its target is to selectively destroy the cancer cells without affecting healthy cells. BioCancell was founded on July 26, 2004 by Avraham Hochberg and is headquartered in Jerusalem, Israel. | Health Technology |
| Consus Ltd. |
- Bolsa de valores
- Insiders
- Gil Milner
- Experiencia
